On-Demand Event

Clinical Challenges in Secondary Prevention of CAD

Original air date:
Tuesday, May 31, 2022

Running time: 1 hour

Featuring : Beth L. Abramson, MD, MSc, FRCP, FACC and Jean-Francois Tanguay, MD, FRCPC


  • Manage the transition from dual anti-platelet therapy at 12 months post-index event to long term antithrombotic management
  • Recognize the myth of the stable CAD patient by demonstrating the rate of recurrent event and mortality over 10 years
  • Define therapeutic options for two typical patient scenarios: 12 months post-PCI and chronic secondary prevention
  • Summarize different therapeutic options and targets for secondary prevention

Language: English